Ionis Pharmaceuticals (IONS) Change in Acquisitions & Divestments (2009 - 2026)

Ionis Pharmaceuticals' Change in Acquisitions & Divestments history runs 18 years deep, the most recent figure standing at $752.8 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 52.16% year-over-year to $752.8 million; the TTM figure through Mar 2026 stood at $2.0 billion (up 17.61% YoY), while the FY2025 annual figure was $1.7 billion, down 4.03% from the prior year.
• Change in Acquisitions & Divestments was $752.8 million for Q1 2026 at Ionis Pharmaceuticals, up from $395.1 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $752.8 million in Q1 2026 to a low of $178.8 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $399.6 million across 5 years, with a median of $385.8 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments slumped 56.58% in 2022, then soared 109.33% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $225.1 million in 2022, then soared by 73.72% to $391.0 million in 2023, then increased by 9.96% to $429.9 million in 2024, then slipped by 8.09% to $395.1 million in 2025, then surged by 90.53% to $752.8 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $752.8 million (Q1 2026), $395.1 million (Q4 2025), and $422.2 million (Q3 2025), per Business Quant data.